Refractory Testicular germ cell cancer

Drug	Drug Name	Drug Description
DB01229	Paclitaxel	A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.

Drug	Drug Name	Target	Type
DB01229	Paclitaxel	Apoptosis regulator Bcl-2	target
DB01229	Paclitaxel	Tubulin beta-1 chain	target
DB01229	Paclitaxel	Cytochrome P450 2C8	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A4	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A5	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A7	enzyme
DB01229	Paclitaxel	Bile salt export pump	transporter
DB01229	Paclitaxel	P-glycoprotein 1	transporter
DB01229	Paclitaxel	Multidrug resistance-associated protein 1	transporter
DB01229	Paclitaxel	Multidrug resistance-associated protein 7	transporter
DB01229	Paclitaxel	Cytochrome P450 19A1	enzyme
DB01229	Paclitaxel	Cytochrome P450 1B1	enzyme
DB01229	Paclitaxel	Solute carrier organic anion transporter family member 1B3	transporter
DB01229	Paclitaxel	Nuclear receptor subfamily 1 group I member 2	target
DB01229	Paclitaxel	Microtubule-associated protein 4	target
DB01229	Paclitaxel	Microtubule-associated protein 2	target
DB01229	Paclitaxel	Microtubule-associated protein tau	target
DB01229	Paclitaxel	Canalicular multispecific organic anion transporter 1	transporter

Drug	Drug Name	Phase	Status	Count